News Author: HT Staff Publish date: December 4, 2016
Kariba area of southern Zambia
where malaria elimination
programs are underway.
Photo from Milen Nikolov
Malaria elimination in historically hig...
News Author: HT Staff Publish date: December 2, 2016
Photo by Juan D.
News Author: HT Staff Publish date: December 2, 2016
Photo courtesy of Merck
The US Food and Drug Administration (FDA) has granted priority review to the supplemental biologics license application (sB...
News Author: HT Staff Publish date: December 1, 2016
Photo by Aaron Logan
Researchers have created a patch designed to monitor a patient’s blood and release heparin as needed to prevent thrombosis.
...
News Author: HT Staff Publish date: December 1, 2016
Photo from Business Wire
The National Institute for Health and Care Excellence (NICE) has issued a final appraisal determination recommending that ...
News Author: HT Staff Publish date: December 1, 2016
(Depo-Testosterone)
Starting testosterone treatment is associated with an increased risk of venous thromboembolism (VTE) that peaks within 6 months...
News Author: HT Staff Publish date: December 1, 2016
beside a normal one
Image by Betty Pace
The European Commission (EC) has designated GBT440 as an orphan medicinal product for the treatment of sic...
News Author: HT Staff Publish date: December 1, 2016
Nausea and Vomiting
©NCCN® 2016
The National Comprehensive Cancer Network (NCCN) has released new educational materials designed to help cancer pa...
News Author: HT Staff Publish date: November 30, 2016
Photo courtesy of Janssen
The National Institute for Health and Care Excellence (NICE) has issued a final appraisal determination recommending that...
News Author: HT Staff Publish date: November 30, 2016
Photo from Business Wire
The US Food and Drug Administration (FDA) has granted full approval for the kinase inhibitor ponatinib (Iclusig®) and upda...
News Author: HT Staff Publish date: November 30, 2016
Photo courtesy of the CDC
Researchers say they have developed biodegradable hydrophilic carriers that could provide oral delivery of factor IX (FIX...
News Author: HT Staff Publish date: November 29, 2016
The US Food and Drug Administration (FDA) has granted fast track designation for tazemetostat as a treatment for patients with relapsed or refracto...
News Author: HT Staff Publish date: November 29, 2016
receiving chemotherapy
Photo by Rhoda Baer
Patients with TP53-mutated myelodysplastic syndromes (MDS) or acute myeloid leukemia (AML) may benefit ...
News Author: HT Staff Publish date: November 29, 2016
The European Commission (EC) has granted conditional marketing authorization for ixazomib (NinlaroTM) to be used in combination with lenalidomide and ...
News Author: HT Staff Publish date: November 28, 2016
caring for a patient
Photo by Tom Watanabe
A new study has revealed which drugs most commonly caused adverse events (AEs) leading to emergency dep...
